TFF Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
TFF Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • TFF Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.96M, a 21% increase year-over-year.
  • TFF Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$19.5M, a 27% increase year-over-year.
  • TFF Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$21.9M, a 31.1% increase from 2022.
  • TFF Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$31.8M, a 0.03% decline from 2021.
  • TFF Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$31.8M, a 70% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$21.9M +$9.9M +31.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$31.8M -$10.1K -0.03% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$31.8M -$13.1M -70% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$18.7M -$6.71M -55.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$12M -$8.09M -208% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
2018 -$3.9M Jan 24, 2018 Dec 31, 2018 10-K 2020-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.